6日前 -Multiple myeloma (MM) is a plasma cell malignancy of the bone marrow. Despite therapeutic advances, MM remains incurable, and better risk stratification as ...
2日前 -Multiple myeloma is a form of cancer in which the immune cells in the bone marrow, known as plasma cells, mutate and become cancerous. Plasma cells are ...
6日前 -Multiple myeloma (MM) is a haematological lymphoid malignancy involving tumoural plasma cells and is usually characterized by the presence of a monoclonal ...
5日前 -Multiple myeloma is one of the most common forms of cancer of the immune cells in the bone marrow. · In multiple myeloma, the immune cells in the bone marrow, ...
17時間前 -Introduction. Multiple myeloma (MM) is a haematological cancer characterized by the expansion of malignant monoclonal plasma cells within the bone marrow. Over ...
... multiple myeloma (MM) in America. He cites systemic issues, delayed ... Triplet regimens for treating multiple myeloma at early relapse. VJHemOnc ...
YouTube-VJHemOnc – Video Journal of Hematology & HemOnc
1日前 -The CARTITUDE-4 study that found that treatment with cilta-cel led to a statistically significant and clinically meaningful improvement in overall survival ...
1日前 -In a major win for Johnson & Johnson and Legend Biotech, their star CAR-T therapy Carvykti showed it can prolong the lives of patients with previously ...
1日前 -Key Takeaways. Ciltacabtagene autoleucel significantly improved overall survival in relapsed/refractory multiple myeloma patients refractory to lenalidomide.
6日前 -Find the latest multiple myeloma news here, including changes in health care legislation, FDA drug approvals research news, inspirational patient stories.
